Strongbridge Biopharma
Strongbridge is a Pennsylvania-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of rare diseases.
Business Model:
Revenue: $34.7M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Strongbridge Biopharma Information
Strongbridge Biopharma was acquired by
Xeris Pharmaceuticals.
The acquisition happend on 2021-05-24.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 900 Northbrook Drive
City: Trevose
State: PA
Zip: 19053
Country: US
Financial Info
Stage:
debt financing
Raised Last:
$30M
Raised Total:$197M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Strongbridge is a Pennsylvania-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of rare diseases.
Contact Phone:
+16102549200
Contact Email:
Strongbridge Biopharma went public on 10/16/2015 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
10/16/2015
Ticker Symbol:
SBBP
IPO Price:
$10/share
Amount Raised:
$25M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2020 | Debt Financing | 1 | $30M |
Armentum Partners Armentum Partners |
1/2015 | Venture Round | 4 | $27.5M |
Broadfin Capital New Enterprise Associates HealthCap RA Capital Management Broadfin Capital New Enterprise Associates HealthCap RA Capital Management |
7/2017 | Post-IPO Debt | 1 | $50M |
CRG CRG CRG CRG |
12/2016 | Post-IPO Debt | 2 | $40M |
Oxford Finance LLC Horizon Technology Finance Oxford Finance LLC Horizon Technology Finance |
12/2016 | Post-IPO Equity | $35M | 7/2017 | Post-IPO Equity | 1 | $3M |
CRG CRG CRG CRG |
10/2015 | IPO | $25M |
|
7/2017 | Debt | $40M |
Capital Royalty L.P |
5/2020 | Debt | $30M |
Avenue Capital Group |
10/2014 | Venture Round | 2 | $11M |
Third Swedish National Pension Fund HealthCap Third Swedish National Pension Fund HealthCap |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 6/2015 | Aspire Pharmaceuticals |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
